Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Shares Issued: 2015-2025

Historic Shares Issued for Editas Medicine (EDIT) over the last 9 years, with Sep 2025 value amounting to $17.1 million.

  • Editas Medicine's Shares Issued was N/A to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year change of. This contributed to the annual value of $590,000 for FY2024, which is 99.50% down from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Shares Issued is $17.1 million, which was up 138.70% from $7.2 million recorded in Q2 2025.
  • Editas Medicine's 5-year Shares Issued high stood at $249.5 million for Q1 2021, and its period low was -$11,000 during Q2 2021.
  • Moreover, its 3-year median value for Shares Issued was $1.4 million (2025), whereas its average is $20.5 million.
  • As far as peak fluctuations go, Editas Medicine's Shares Issued crashed by 100.01% in 2021, and later spiked by 78,490.60% in 2023.
  • Over the past 5 years, Editas Medicine's Shares Issued (Quarterly) stood at $1,000 in 2021, then surged by 61,100.00% to $612,000 in 2022, then soared by 78,490.60% to $117.1 million in 2023, then crashed by 99.89% to $268,000 in 2024, then surged by 5,426.15% to $17.1 million in 2025.
  • Its Shares Issued stands at $17.1 million for Q3 2025, versus $7.2 million for Q2 2025 and $1.4 million for Q1 2025.